Is Muscle Pain a Symptom of Myotonic Dystrophy?
At a Glance
Yes, chronic muscle pain is a very real, well-documented symptom of both types of myotonic dystrophy. It is a hallmark feature of type 2 (DM2) and can include burning nerve pain. Managing this pain requires specialized care, especially to monitor heart health when using medications.
In this answer
2 sections
Yes, chronic and significant muscle pain is a very real, well-documented symptom of myotonic dystrophy [1][2]. While muscle weakness and stiffness are widely known, pain is often heavily under-recognized in neuromuscular diseases. If your muscles hurt all the time, your experience is valid, and addressing this pain is an important part of managing your overall health [3].
While pain can occur in anyone with myotonic dystrophy, its presentation can vary depending on the type you have:
- A Hallmark of DM2: While muscle weakness is a common feature across all types, prominent and chronic muscle pain (myalgia) is a hallmark feature that often distinguishes myotonic dystrophy type 2 (DM2) [1][4]. Research links this pain directly to molecular changes within the muscles themselves [4]. People with DM2 frequently experience mechanical hyperalgesia, meaning they feel pain from physical pressure or touches that would not normally be painful [1][5].
- Pain in DM1: People with myotonic dystrophy type 1 (DM1) also experience significant pain and may even show a higher overall sensitivity to pain than those with DM2 [5]. In both types, damage to the small sensory nerves in the skin (small-fiber neuropathy) can contribute to a burning or tingling pain [6][5].
Differentiating Myotonic Dystrophy Pain from Fibromyalgia
Because severe muscle pain and fatigue are so common in DM2, patients are sometimes misdiagnosed with primary pain conditions like fibromyalgia before their genetic diagnosis is confirmed [7][8]. If you have been diagnosed with fibromyalgia but also have early cataracts or a family history of muscle stiffness, it is important to mention these to your doctor, as the conditions are fundamentally different:
- Source of the Pain: Fibromyalgia is generally considered a problem with how the brain and spinal cord process pain signals (central sensitization). In contrast, the pain in myotonic dystrophy originates from damage and changes in the peripheral nerves and muscles themselves (peripheral mechanism) [1][5].
- Accompanying Symptoms: Myotonic dystrophy involves systemic features that fibromyalgia does not, such as grip stiffness (myotonia), potential heart rhythm issues, and specific patterns of muscle weakness (such as weakness in the face, hands, and lower legs in DM1, or weakness closer to the center of the body, like the hips and shoulders, in DM2) [9][10][11].
Approaches to Managing the Pain
Treating pain in myotonic dystrophy requires a careful, coordinated approach because the disease affects multiple systems in your body [12][13]. Standard over-the-counter pain relievers may not fully address nerve or stiffness-related pain, and standard guidelines for pain management in myotonic dystrophy are not widely established, highlighting the need for a specialized care team [1].
- Medication: Treatment depends on the source of your pain. Certain medications, such as mexiletine, can effectively treat muscle stiffness and the pain directly associated with that stiffness [14][1]. Different medications may be required if your pain is driven by nerve damage. However, because myotonic dystrophy can cause heart problems, doctors must strictly monitor your heart health—usually with an EKG (electrocardiogram)—before and during treatment with medications like mexiletine to ensure your heart rhythm remains safe [15][16][17].
- Holistic and Behavioral Strategies: Pain intensity is often linked to emotional factors, stress, and fatigue [2]. Cognitive and behavioral interventions, along with carefully paced physical therapy tailored to avoid overworking weakened muscles, can be highly effective in reducing the impact pain has on your daily life [2]. Addressing pain may also improve your sleep, as chronic pain contributes to sleep disruptions [18].
Common questions in this guide
Is severe muscle pain a normal symptom of myotonic dystrophy?
How is myotonic dystrophy pain different from fibromyalgia?
What causes the burning nerve pain in myotonic dystrophy?
What are the safe options for treating myotonic dystrophy pain?
Can physical therapy help with myotonic dystrophy muscle pain?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific pain management options are safe for me, considering the heart risks associated with myotonic dystrophy?
- 2.Should I be evaluated for small-fiber neuropathy as a potential cause of my pain, and how would that change my treatment plan?
- 3.Before prescribing any new medications for my muscle stiffness or pain, such as mexiletine, what specific heart monitoring or EKGs will you order?
- 4.How can we clearly differentiate my myotonic dystrophy pain from other possible conditions, and should I be referred to a specialized pain clinic?
- 5.Can you recommend a physical therapist who has specific experience working with neuromuscular diseases so I don't overwork my muscles?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2.
van Vliet J, Tieleman AA, Verrips A, et al.
The journal of pain 2018; (19(8)):920-930 doi:10.1016/j.jpain.2018.03.006.
PMID: 29601898 - 2
Multidimensional aspects of pain in myotonic dystrophies.
Peric M, Peric S, Rapajic N, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2015; (34(2-3)):126-32.
PMID: 27199540 - 3
Health-related quality of life, pain, and fatigue in myotonic dystrophy type 2: a 13-year follow-up study.
Damen MJ, Mul K, van Engelen BGM, et al.
Disability and rehabilitation 2025; 1-8 doi:10.1080/09638288.2025.2571068.
PMID: 41173243 - 4
A Molecular Signature of Myalgia in Myotonic Dystrophy 2.
Moshourab R, Palada V, Grunwald S, et al.
EBioMedicine 2016; (7()):205-11.
PMID: 27322473 - 5
Characterization of the neuropathic pain component contributing to myalgia in patients with myotonic dystrophy type 1 and 2.
Schmitt V, Baeumler P, Schänzer A, et al.
Frontiers in neurology 2024; (15()):1414140 doi:10.3389/fneur.2024.1414140.
PMID: 39193143 - 6
Small and large fiber neuropathy in adults with myotonic dystrophy type 1.
Solbakken G, Løseth S, Frich JC, et al.
Frontiers in neurology 2024; (15()):1375218 doi:10.3389/fneur.2024.1375218.
PMID: 38504800 - 7
No relevant excess prevalence of myotonic dystrophy type 2 in patients with suspected fibromyalgia syndrome.
van Vliet J, Verrips A, Tieleman AA, et al.
Neuromuscular disorders : NMD 2016; (26(6)):370-3.
PMID: 27132119 - 8
Myotonic Dystrophy.
Perez PG
Continuum (Minneapolis, Minn.) 2025; (31(5)):1437-1461 doi:10.1212/cont.0000000000001621.
PMID: 41037177 - 9
Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient.
Miyashita K, Ii Y, Matsuyama H, et al.
Internal medicine (Tokyo, Japan) 2023; (62(20)):3027-3031 doi:10.2169/internalmedicine.0425-22.
PMID: 36792202 - 10
Graves' disease and celiac disease in a patient with myotonic dystrophy type 2.
Damen MJ, van der Meer A, Voermans NC, Tieleman AA
Neuromuscular disorders : NMD 2018; (28(10)):878-880 doi:10.1016/j.nmd.2018.07.003.
PMID: 30197184 - 11
Myotonic Muscular Dystrophy Type 2 in CT, USA: A Single-Center Experience With 50 Patients.
Roy B, Wu Q, Whitaker CH, Felice KJ
Journal of clinical neuromuscular disease 2021; (22(3)):135-146 doi:10.1097/CND.0000000000000340.
PMID: 33595997 - 12
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, et al.
Neurologia 2020; (35(3)):185-206 doi:10.1016/j.nrl.2019.01.001.
PMID: 31003788 - 13
A rare case report of severe cardiomyopathy associated with myotonic dystrophy type 2.
Touma AM, Nijjar PS, Manousakis GE, Kamdar F
European heart journal. Case reports 2022; (6(3)):ytac015 doi:10.1093/ehjcr/ytac015.
PMID: 35350724 - 14
Long-term Safety and Efficacy of Mexiletine in Myotonic Dystrophy Types 1 and 2.
Mousele C, Matthews E, Pitceathly RDS, et al.
Neurology. Clinical practice 2021; (11(5)):e682-e685 doi:10.1212/CPJ.0000000000001073.
PMID: 34840883 - 15
Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy.
Wahbi K, Bassez G, Duchateau J, et al.
Archives of cardiovascular diseases 2024; (117(6-7)):450-456 doi:10.1016/j.acvd.2024.03.001.
PMID: 38677940 - 16
Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.
McNally EM, Mann DL, Pinto Y, et al.
Journal of the American Heart Association 2020; (9(4)):e014006 doi:10.1161/JAHA.119.014006.
PMID: 32067592 - 17
Risk of Cardiac Disease in a Population-Based Cohort of Myotonic Dystrophy Type 1 and Type 2 in the United States.
Johnson NE, Bhandaru V, Andrews JG, et al.
Neurology. Genetics 2025; (11(6)):e200322 doi:10.1212/NXG.0000000000200322.
PMID: 41170323 - 18
Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.
Romigi A, Maestri M, Nicoletta C, et al.
Current neurology and neuroscience reports 2019; (19(2)):9 doi:10.1007/s11910-019-0924-0.
PMID: 30739220
This page is for informational purposes only and does not replace professional medical advice. Always consult your neurologist or care team before starting new pain management treatments, especially considering the heart health risks associated with myotonic dystrophy.
Get notified when new evidence is published on Myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.